<SEC-DOCUMENT>0000914475-24-000183.txt : 20240801
<SEC-HEADER>0000914475-24-000183.hdr.sgml : 20240801
<ACCEPTANCE-DATETIME>20240801105130
ACCESSION NUMBER:		0000914475-24-000183
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		16
REFERENCES 429:			333-240301
REFERENCES 429:			333-266530
REFERENCES 429:			333-273554
FILED AS OF DATE:		20240801
DATE AS OF CHANGE:		20240801
EFFECTIVENESS DATE:		20240801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEUROCRINE BIOSCIENCES INC
		CENTRAL INDEX KEY:			0000914475
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				330525145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-281163
		FILM NUMBER:		241164985

	BUSINESS ADDRESS:	
		STREET 1:		6027 EDGEWOOD BEND COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 617-7600

	MAIL ADDRESS:	
		STREET 1:		12780 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>nbix-20240801xs8.htm
<DESCRIPTION>S-8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i2d331282b9974ef5a13745d125bf871b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">As filed with the Securities and Exchange Commission on August 1, 2024</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><br>Registration No. 333-</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">FORM S-8</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">REGISTRATION STATEMENT</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">UNDER</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">THE SECURITIES ACT OF 1933</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:115%">NEUROCRINE BIOSCIENCES, INC.</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Exact Name of Registrant as Specified in Its Charter)</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">33-0525145</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or Other Jurisdiction of Incorporation or Organization)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(I.R.S. Employer Identification No.)</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6027 Edgewood Bend Court</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">San Diego, CA 92130</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(Full Title of the Plan)</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kevin C. Gorman, Ph.D.</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neurocrine Biosciences, Inc.</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12780 El Camino Real</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">San Diego, CA 92130</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Name and Address of Agent for Service)</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(858) 617-7600</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Telephone Number, Including Area Code, of Agent for Service)</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><br><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Copies to&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Darin M. Lippoldt</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Jason L. Kent, Esq.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Chief Legal Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Carlos A. Ramirez, Esq.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Neurocrine Biosciences, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cooley LLP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">12780 El Camino Real</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10265 Science Center Drive</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">San Diego, CA 92130</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">San Diego, CA 92121</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(858) 617-7600</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(858) 550-6000</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.<br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Large accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744; (Do not check if a smaller reporting company)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Smaller reporting company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company  &#9744;</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  &#9744;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">INCORPORATION BY REFERENCE OF CONTENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF REGISTRATION STATEMENTS ON FORM S-8<br><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Registration Statement on Form S-8 is being filed for the purpose of increasing the number of securities of the same class as other securities for which Registration Statements on Form S-8 relating to the same benefit plan are effective. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Registration Statement on Form S-8 registers the offer and sale of an additional 3,635,000 shares of the Registrant&#8217;s common stock for issuance </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan (as amended and restated, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2020 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Registrant previously registered shares of its common stock for issuance under the 2020 Plan on August 3, 2020 (File No. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">333-240301</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), August 4, 2022 (File No. 333-266530) and August 1, 2023 (File No. 333-273554).</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ITEM 8.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EXHIBITS.</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Description</font></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000156459018026844/nbix-ex31_91.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Certificate of Incorporation, as amended. (1)</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000091447523000057/q2-2023xexhibit3_2.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Bylaws, as amended. (2)</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000119312524148107/d836271dex31.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Certificate of Amendment of Bylaws</a><a href="https://www.sec.gov/Archives/edgar/data/914475/000119312524148107/d836271dex31.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">. (3)</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference is made to Exhibits </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000156459018026844/nbix-ex31_91.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000091447523000057/q2-2023xexhibit3_2.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.2</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000119312524148107/d836271dex31.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.</a><a href="https://www.sec.gov/Archives/edgar/data/914475/000119312524148107/d836271dex31.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/0000898430-96-002108.txt" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Form of Common Stock Certificate of the Registrant. (</a><a href="https://www.sec.gov/Archives/edgar/data/914475/0000898430-96-002108.txt" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">4</a><a href="https://www.sec.gov/Archives/edgar/data/914475/0000898430-96-002108.txt" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">)</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="nbix-20240801xs8exhibit51.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Opinion of Cooley LLP.</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="nbix-20240801xs8exhibit51.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Consent of Cooley LLP (included in Exhibit 5.1 filed herewith).</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="nbix-20240801xs8exhibit232.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm.</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i2d331282b9974ef5a13745d125bf871b_4" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Power of Attorney (included on the signature page hereto).</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/914475/000091447524000181/q2-2024xexhibit101.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, as amended and restated. (</a><a href="https://www.sec.gov/Archives/edgar/data/914475/000091447524000181/q2-2024xexhibit101.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">5</a><a href="https://www.sec.gov/Archives/edgar/data/914475/000091447524000181/q2-2024xexhibit101.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">)</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">107</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="wk-20240731.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Filing Fee Table</a></font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 5, 2018</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(2) </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 1, 2023.</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(3) </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Incorporated by reference to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Exhibit 3.1 of the Registrant&#8217;s Current Report on Form 8-K filed on May 28, 2024.</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(4) </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Incorporated by reference to the Registrant&#8217;s Registration Statement on Form S-1 (Registration No. 333-03172).</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(5) Incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 1, 2024.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d331282b9974ef5a13745d125bf871b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on August 1, 2024.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NEUROCRINE BIOSCIENCES, INC.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Kevin C. Gorman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Kevin C. Gorman, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chief Executive Officer</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">POWER OF ATTORNEY</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">KNOW ALL PERSONS BY THESE PRESENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, that each person whose signature appears below constitutes and appoints KEVIN C. GORMAN, PH.D., and DARIN LIPPOLDT, and each or either of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Date</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Kevin C. Gorman</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Chief Executive Officer and Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Kevin C. Gorman, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Matthew C. Abernethy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Matthew C. Abernethy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; William H. Rastetter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Chairman of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">William H. Rastetter, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Gary A. Lyons</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Gary A. Lyons</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Johanna Mercier</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Johanna Mercier</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; George J. Morrow</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">George J. Morrow</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Leslie V. Norwalk</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Leslie V. Norwalk</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Christine A. Poon</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Christine A. Poon</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Richard F. Pops</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Richard F. Pops</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#47;s&#47; Shalini Sharp </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Shalini Sharp </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stephen A. Sherwin</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">August 1, 2024</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stephen A. Sherwin, M.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>wk-20240731.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:6b9a96fc-59df-4475-a7d5-c4caa9f95804,g:8a1838a7-139f-49e9-84bc-5079e1d71851,d:5340e5ff2bf1431b871ae62f6e4ed7fe-->
<html xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>wk-20240731</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-1">0000914475</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-2">NEUROCRINE BIOSCIENCES, INC.</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ffd:FormTp" id="f-3">S-8</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ffd:SubmissnTp" id="f-4">S-8</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ffd:FeeExhibitTp" id="f-5">EX-FILING FEES</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5340e5ff2bf1431b871ae62f6e4ed7fe_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 107</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Calculation of Filing Fee Table</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Form S-8</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Neurocrine Biosciences, Inc.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Table 1 &#8211; Newly Registered Securities</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Security<br/>Type</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Security Class<br/>Title</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fee<br/>Calculation<br/>Rule</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Registered</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Proposed<br/>Maximum<br/>Offering<br/>Price Per<br/>Unit</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Aggregate<br/>Offering<br/>Price</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fee Rate</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of<br/>Registration<br/>Fee</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><ix:nonNumeric contextRef="c-2" name="ffd:PrevslyPdFlg" format="ixt:fixed-false" id="f-6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to be</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Paid</span></div></ix:nonNumeric></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingSctyTp" id="f-7">Equity</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingSctyTitl" id="f-8">Common stock, $0.001 par value per share, 2020 Equity Incentive Plan</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><ix:nonNumeric contextRef="c-2" name="ffd:FeesOthrRuleFlg" format="ixt:fixed-true" id="f-9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></ix:nonNumeric></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="ffd:AmtSctiesRegd" format="ixt:num-dot-decimal" scale="0" id="f-10">3,635,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="3" name="ffd:MaxOfferingPricPerScty" scale="0" id="f-11">146.185</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ffd:MaxAggtOfferingPric" format="ixt:num-dot-decimal" scale="0" id="f-12">531,382,475.00</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-2" decimals="7" name="ffd:FeeRate" scale="0" id="f-13">0.0001476</ix:nonFraction></span></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ffd:FeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">78,432.05</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Offering Amounts</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ffd:TtlOfferingAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">531,382,475.00</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ffd:TtlFeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">78,432.05</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Fee Offsets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ffd:TtlOffsetAmt" format="ixt:fixed-zero" scale="0" id="f-17">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Fee Due</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ffd:NetFeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-18">78,432.05</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:8pt"><td colspan="27" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingNote" id="f-19" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of Neurocrine Biosciences, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that become issuable under the Registrant&#8217;s 2020 Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant&#8217;s common stock, as applicable.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Estimated in accordance with Rule 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of 146.185 per share of common stock, which represents the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on July 26, 2024.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Represents 3,635,000 additional shares of Registrant&#8217;s common stock that were added to the shares authorized for issuance under the 2020 Plan on May 22, 2024 pursuant to approval of the stockholders at the 2024 Annual Meeting of Stockholders.</span></div></ix:nonNumeric></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>nbix-20240801xs8exhibit51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9e84ef11dfb3445a9a300125d8271c51_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div></div><div><img alt="image_1a.jpg" src="image_1a.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:136px"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carlos A. Ramirez</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+1 858 550 6157</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cramirez&#64;cooley.com</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 1, 2024</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12780 El Camino Real</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, CA 92130</font></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have acted as counsel to Neurocrine Biosciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), in connection with the filing by the Company of a Registration Statement on Form S&#8209;8 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with the Securities and Exchange Commission (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), covering the offering of up to </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,635,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the Company&#8217;s common stock, $0.001 par value, pursuant to the Company&#8217;s 2020 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this opinion, we have examined and relied upon (a) the Registration Statement and the related prospectus, (b) the Plan, (c) the Company&#8217;s certificate of incorporation and bylaws, each as currently in effect, and (d) such other records, documents, opinions, certificates, memoranda and instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Plan, the Registration Statement and the related prospectus, will be validly issued, fully paid, and nonassessable (except as to Shares issued pursuant to deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This opinion is limited to the matters expressly set forth in this letter, and no opinion has been or should be implied, or may be inferred, beyond the matters expressly stated. This opinion speaks only as to law and facts in effect or existing as of the date hereof and we have no obligation or responsibility to update or supplement this opinion to reflect any facts or circumstances that may hereafter come to our attention or any changes in law that may hereafter occur.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.</font></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cooley LLP</font></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Carlos A. Ramirez</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carlos A. Ramirez</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">10265 Science Center Drive, San Diego, CA 92121  T&#58; (858) 550-6000  F&#58; (858) 550-6420  www.cooley.com</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>nbix-20240801xs8exhibit232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i6cd14657aac9403baa1ac11e96682983_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan (as amended and restated) of our reports dated February 9, 2024, with respect to the consolidated financial statements of Neurocrine Biosciences, Inc. and the effectiveness of internal control over financial reporting of Neurocrine Biosciences, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Ernst &#38; Young LLP</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">San Diego, California</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">August 1, 2024</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1a.jpg
M_]C_X  02D9)1@ ! 0$$#0%3  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %3! T# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \3_ &SO^3:_&'_;G_Z605^7M?J%^V=_R;7XP_[<
M_P#TL@K\O:^7S3^,O3]6?U+X6?\ (EJ_]?9?^D0"BBBO'/V,*_7CX'_\D6\
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M /2:.O<RKXY>A^%^*W^Y87_$_P CMJ***^D/YK"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!XG^V=_R;7XP_[<__ $L@K\O:_4+]L[_DVOQA_P!N?_I9
M!7Y>U\OFG\9>GZL_J7PL_P"1+5_Z^R_](@%%%%>.?L85^O'P/_Y(MX _[%_3
M_P#TFCK\AZ_7CX'_ /)%O '_ &+^G_\ I-'7N95\<O0_"_%;_<L+_B?Y';44
M45](?S6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445RWQ*^)6@_"?PE=^(O$5W]FLH?E2- &EN)2"5BB7(W.V#QP
M 22%!(4I**N]C:C1J8BI&C1BY2D[)+=L/B5\2M!^$_A*[\1>(KO[-90_*D:
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M*>,?^1_B_P#%^B"BBBNP^-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"D0"BBBO'/V,*_7CX'_P#)%O '_8OZ?_Z31U^0]?KQ\#_^2+> /^Q?T_\
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MC?\ 0%\+_P#@+<__ "11_P /#OB-_P! 7PO_ . MS_\ )%<_]I8?N_N/HO\
MB&V?_P L?_ D?H;17YY?\/#OB-_T!?"__@+<_P#R17TI^R=\;?%_QST7Q!JW
MB/3-+LM/M+B*ULIM-1T\R7:6F5@\KGY0T)!P!\YZX.-J6-I5IJ$+W/(S7@K-
MLFPDL;BU%0C;:2;U=M%U_P KL]E\5>(K;PCX7UC7;Q)9;32[.:]F2  R,D:%
MV"@D G"G&2!GN*_'/7-:O/$FM:AJVHS?:-0O[B2ZN9MJKOE=BSMA0 ,DDX
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M_;G_ .ED%?E[7ZA?MG?\FU^,/^W/_P!+(*_+VOE\T_C+T_5G]2^%G_(EJ_\
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M&'_;G_Z605^7M?+YI_&7I^K/ZE\+/^1+5_Z^R_\ 2(!1117CG[&%?KQ\#_\
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MD[+M;WO4^*/^';?_ %43_P HG_W14"?\$YXY+V6U'Q"E$L4:2LS>'G$9#%@
M',^UC\ARH)*@J2 &7/V]7$_%2TU*ST6/Q/H-E_:'B#P_ONX+)693?0%<7%IE
M%9CO3YD4#!FB@8@A,5U2P.&BK\GXO_,^6PW'7$=>JJ3Q=G+1>Y3M?I?W=F]&
M^F_0^+_'G_!/GQGH,+S^&-7L/%,21J3;R+]BN7<O@JBLS1D!<-N:12?F&,@;
MO /'WPO\5?"[4DL/%.AW6CSR9\II5#13856/ERJ2CX#KG:QP3@X/%?KCX7\4
M:5XT\/V.N:'?1:EI5['YL%S"3M89P00>00005(!!!! ((J;6M#T[Q)ILVG:M
MI]KJFGS;?-M+V%9HGPP8;D8$'! (R.H!K"IEM*:O2=OQ1[V7^)F;8*I[',Z:
MJ).STY)K[O=T[<J]4?B_17VA^T+^PO'I]E>^(_ANLKQ01H\GAD[YI"%!\QX)
M&8LYX4^4V23OVL3MCKXOKP*U">'ERS1^_P"2Y[@<_P /]8P4[VW3TE%]FOU5
MT^C84445SGT!Z'\!OB[>?!7XCV'B"W'F63XM=2@$2R--:,ZF14!(PXVAE.X?
M,HSE20?U=T/6K/Q)HNGZMITWVC3[^WCNK:;:R[XG4,C88 C((." :_%^OLK]
M@?XW2VNI/\--3;?;7/G7FDS,\C,DH4-);@<JJ%5>4?= 8/\ >,@Q[678GV<O
M92V>WJ?BWB-PU]>PW]K89?O*2][SAW]8[^E^R/N2BBBOIC^8 KX-_P""@GPG
M_LCQ+IOQ LH\6VK;;#4.>ERB?NGY?/SQ(5PJ@#R,DY>OO*N6^*'@&S^*/P_U
MSPM?MY4&I6YC6;#'R900T4F R[MDBHVW(!VX/!-<N*H^WI.'7IZGU?"^=2R'
M-*6,O[GPS\XO?[M)+S2/QZHJ]KFBWGAO6M0TG48?L^H6%Q):W,.Y6V2HQ5UR
MI(."",@D51KXK;1G]MQE&<5*+NF%%%%(H_2[]B;XF2>/_@Q:Z?>2Q/J7AV0:
M8RK(AD:W508'**!L&TF,$YW&%CDG./H"OR]_9'^,'_"I?BU9?;;GR/#^LXT_
M4/,DVQQ[C^ZG;+JHV/C+MG;&\N!DU^H5?7X&M[:BD]UH?QYQYDKRC.)R@K4Z
MOOQ[:_$OD^G9H****]$_.@HHHH **** "OD/_@H)\6/[(\-:;\/[*3%SJVV_
MU#CI;(_[I.4Q\\J%LJP(\C!&'KZUOKZVTNRN+R\N(K2TMXVFFN)W"1Q(H)9F
M8\   DD\ "OR.^-7Q$_X6M\4O$7BE8/L\%_<#[/&4VL($58XMXW-\_EHF[!(
MW9QQBO*S&M[.ER+>7Y'ZQX<Y*LRS7ZW55X4/>\N?[/W:R]4CB:***^4/ZP"B
MBO>?V+OAK+X\^-FF7\MIY^D>'_\ B97,C&1565<BW4,HQO\ -VN%8@,L3]<$
M'6G3=6:@NIYF9X^GE>"JXVM\-.+?K;9>K>B\V?<G[-GPG_X4Y\)=*T6>/9J]
MQF_U/G/^DR ;DX=E^152/*G#>7NQ\QKU&BBON(05.*A'9'\+8S%UL?B:F*KN
M\YMM^K_3LNB/R'^.'_):?'__ &,&H?\ I3)7$UU_QB>YD^+GC=KR**"[;7+X
MS102F6-'^T/N57*J6 .0&*J2.<#I7(5\-4^-^I_=F7JV#HK^['\D%%%%9GH!
M7[3V-C;:796]G9V\5I:6\:PPV\"!(XD4 *JJ.     . !7XOV+VT=[;M>12S
MVBR*9HH)1%(Z9&Y5<JP4D9 8JP!YP>E?M/7T&4_;^7ZG\]^+,G_L4>G[S_VS
M^OF%%%%?0'\]A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!1US6K/PWHNH:MJ,WV?3["WDNKF;:S;(D4L[84$G !. ":_(CXH>/KS
MXH_$#7/%-^GE3ZE<&18<J?)B "Q1Y"KNV1JB[L G;D\DU]A?\%!OBM<Z3H^D
M> M/N8E758S>ZI$T),GDI(OV<!R-H#21R$X^;,2\@$AOA2OF<RK\\U26R_,_
MI[PSR+ZG@I9K57OU=(^4$_\ VYJ_HHOJ%%%%>*?M05/8V-SJE[;V=G;RW=W<
M2+##;P(7DE=B JJHY))(  Y)-05]\_L3?LWR>$;*U^(NOF)]2U*S!TJS54D%
MM;R@,)RV#B1UX 4C:CL&R7*IU8>A+$3Y%\SYCB+/L/P]@98NMK+:,?YI=O3N
M^GK8N_LT_L8VWP[O=/\ %GC*2+4O$4<:S6VEJ@:#3ILD[BV2)9%&W! "HVXC
M>0CCZHHHK["C1A1CRP1_'&;9QC<[Q+Q6-GS2Z=$EV2Z+\7NVWJ%%%%;'BA11
M10 4444 >:_&OX!^&/C=X?GM=4M8K361&%L]<AA4W-L5+%03P7CR[9C)P=Q(
MVMAA^8GQ*^&NO?"?Q;=^'?$5I]FO8?F21"6BN(B3MEB; W(V#SP0000&! _8
M6O-?CY\%-*^-W@6ZTNZ@B&LV\<DNDW[,4:VN"O +!6/EL0H=<'(&0-RJ1Y>,
MP:KKGA\7YGZEP;QE6R.LL)BVY8>3^<'W7EW7S6N_Y-T5>US1;SPWK6H:3J,/
MV?4+"XDM;F'<K;)48JZY4D'!!&02*HU\IMHS^M(RC.*E%W3"BBBD4?JM^S3\
M9K;XS_#/3[Z6[BE\164:VVKVZL/,689 E*A5 $H7>-HV@EE!)0X]8K\ROV+O
MB5+X#^-FF6$MWY&D>(/^);<QL)&5I6R;=@JG&_S=J!F!"K*_3)(_36OL<%7]
MO23>ZT9_&G&N11R'-I4Z*_=3]Z/DFW>/R>WE:X4445WGP05E^*/%&E>"_#]]
MKFN7T6FZ591^;/<S$[5&<  #DDD@!0"22  20*U*^-?^"AWQ*ELM-\/>!K*[
M\O[;NU+485$BLT2MM@4D$*R,XE8J<D-"AXP,\^(K>PI.9]%P_E$L\S.C@4[*
M3U:Z16K?W;7ZV/D3XH>/KSXH_$#7/%-^GE3ZE<&18<J?)B "Q1Y"KNV1JB[L
M G;D\DURU%%?$RDY-R>[/[@HT:>'I1HTE:,4DEV2T2^X****DV)[&QN=4O;>
MSL[>6[N[B188;>!"\DKL0%55')))  '))K]$_P!F']D?3OAAIL&O>+K*UU3Q
MC-LE2*55FBTO#!E$?4&8$ F4=",(<99\O]B;]GJV\'^%[7QYKME%)XBU2,3:
M:S2"06ME(@*L !A9) 6).20A5?E)D4_5%?2X'!**56IOT/YHXZXTJ8JI/*LN
ME:G%VG)/XFNB:^RNO?TW****]L_#@HHHH **** "O&OVD/V;]*^/'A\21F+3
M?%EE&18:FRG:PR3Y$V!DQDDX/)0DL,Y97]EHK.I3C4BX35TST,!C\3EF)AB\
M)/EG'9_H^Z?5=3\>OB5\-=>^$_BV[\.^(K3[->P_,DB$M%<1$G;+$V!N1L'G
M@@@@@,"!RU?JM^TA\";;X\>!1IJ3Q6&N6,AN=-O9(P5#[2&B<X+"-^-VWD%4
M;#;=I_+?7-%O/#>M:AI.HP_9]0L+B2UN8=RMLE1BKKE20<$$9!(KY+%X5X:>
MGPO8_KOA'BBGQ)A+SM&M#XHK\)+R?SL].UZ-%%%<!]Z%?J[^S9\6/^%Q_"72
MM:GDWZO;YL-3XQ_I,8&Y^$5?G5DDPHPOF;<_*:_**OH#]BOXK7/P_P#B_8Z-
M)<Q0Z'XED2RNUDA+L9@'%L4*C*GS7"?W<2,6' 9?2P%?V-6SV>G^1^;<>Y%_
M;.4RJTU^]HWE'S5O>C\TKKNTD?I=1117UQ_( 4444 >)_MG?\FU^,/\ MS_]
M+(*_+VOU"_;._P"3:_&'_;G_ .ED%?E[7R^:?QEZ?JS^I?"S_D2U?^OLO_2(
M!1117CG[&%?KQ\#_ /DBW@#_ +%_3_\ TFCK\AZ_7CX'_P#)%O '_8OZ?_Z3
M1U[F5?'+T/POQ6_W+"_XG^1VU%%%?2'\UA4%]?6VEV5Q>7EQ%:6EO&TTUQ.X
M2.)%!+,S'@  $DG@ 5/7S_\ ML_$R3P!\&+K3[.6)-2\12'3%5I$$BV[*3.X
M1@=XV@1DC&TS*<@XSE5J*E!S?0]7*LOJ9ICJ."I;SDEZ+J_DKL^#OCC\4KGX
MQ?$S6?$DIE6TFD\FPMY208+5.(EV[F"DCYF"G;O=R.M<%117PTI.<G*6[/[J
MPN&I8.A##T5:$$DEY+0***[WX'?"VY^,7Q,T;PW$)5M)I/.O[B($&"U3F5MV
MU@I(^52PV[W0'K1&+G)1CNPQ6)I8.A/$5G:$$VWY+4]R_8T_9AL_B%M\<^*X
M/M&@VMP8[#2YHFV7TJ8S))D8>%2=NT9#.K!L!2K_ '_4%C8VVEV5O9V=O%:6
MEO&L,-O @2.)% "JJC@    #@ 5/7VF'P\</#E6_4_BCB+/\3Q#C98FL[16D
M8](K_-]7U]$@HHHKJ/EPHHHH ^>?".HS_L__ !LE\#W[[/ OC*XDN_"[&XB6
M+3KG[]Q:"/:NQ'DD4(JY +1@!F>0K]#5Y=^TG\)_^%Q_"75=%@CWZO;XO],Y
MQ_I,8.U.75?G5GCRQPOF;L?**Y[]E7]H6V^-/@V*SU2]B/C738\:A;^6(C.@
M;"W"*#@@@J'VX"N3\JJR9XX2]E4]B]GJOU7R_(^SQN'>;9>LWI*\Z=H5DO\
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M]E??=V\D^H4445]"?SL?D/\ '#_DM/C_ /[&#4/_ $IDKB:]8_:K\.VWA?\
M:$\;6=J\LD4MXMZ3,06WW$:3N!@#@-*P'? &23R?)Z^$K+EJ23[L_O+**D:V
M78:K#:4(-?.*"BBBLCU@K]H-#UJS\2:+I^K:=-]HT^_MX[JVFVLN^)U#(V&
M(R"#@@&OQ?K]:_V=]:L]>^!?@2YL)O/@CT>VM6;:RXEAC$,JX('22-UST.,C
M(P:]W*I>].)^#^*]#FPN$Q&ONRDO+WDG]_NZ?,]#HHHKZ,_F\**** "BBB@
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M_(EJ_P#7V7_I$ HHHKQS]C"OUX^!_P#R1;P!_P!B_I__ *31U^0]?KQ\#_\
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M2  R,D<JNP4$@$X4XR0,]Q7[&5]-E<[TY0[/\S^8?%/!>QS*CBUM4A;YQ?\
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M \9/6NOK[RFK0BO(_@C,INICJ\Y.[<Y/7?=[A1116AYP4444 %%%% !1110
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M/[BJ[Q?1-[Q\K;KR]';4HHHKTC\V"BBB@ HHHH **** "BBB@ HHHH ****
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MK?W:?>%%%%?/']#!7V]_P3>L;F.R\?WC6\JVDTEC#'<,A$;N@G+J&Z$J)$)
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M:7JEU90O.09&2.5D4L0 "<*,X &>PKP,V6D'Z_H?O_A-5BJF-I/=J#^[FO\
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M?%#Q]9_"[X?ZYXIOT\V#3;<R+#EAYTI(6*/(5MN^1D7=@@;LG@&OAO\ 8/\
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MHTI)SM&W:!@DYXP?$_&7[>'Q,\07H;1IK#PM:1R2%(K2U2XD=&(V+(\P<,5
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M_P W'F[MI(4#>@)):7GQ,RP_/'VL=UOZ'[?X:<01PF(EE.(E:-1WAY2MJO\
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MK)Z-K^ZNM^[T]=GVW[67[3G_  NK4H]!T)/*\':;<>=#+)'B6]G"LHF.1E$
M9@J<$AB6Y(5/GBBBOEJM25:;G/<_JK+,LPV3X2&#PD;0C][?5M]6_P"M K]#
M?V'OCO\ \)WX2_X0C5IMVO:#;C[(5@V++IZ!(TRPX+QE@AR%RI0_,=YK\\JV
M_!/C#4O 'BW2?$6DR^5J&FW"W$668*^#RC[2"4895@",JQ'>ML+B'AZBETZG
MC\49#3XARZ6%EI-:P?:7^3V?W]#]DZ*R_"NK7.O^%]'U2\T^72+N]LX;F;3Y
M\^9:NZ!FB;(4Y4DJ<@'(Z#I6I7VB=U<_B><)4Y.$MUH%%%%,@**** "BBB@
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M%#.20,LQQTR3ZUET5$JM2?QR;.S"Y9@,"^;"T(4W_=BH_DD%%%%9'IA1110
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M+=BKMDL/F.$P&^8L-I^Z_@_^SUX,^",,S>'K*634KB/R9]4OI/-N94WE@N0
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M=XCX\94^4FORL9?AWPKHOA&R>ST+1[#1;220S/;Z=:I;QLY !8J@ )PJC/7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6***^YA!4XJ$=D?PICL95S#%5,76=Y3;;^?]:!1115G$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(
M?VK/B5+\,/@GK=_97?V/5[[;IMA(!(&$LN0S(R$%'6(2NK$@!D'7@'UZOS8_
M;<^+'_"POBU)HMI)NTCPQYEA'QC?<DC[2_*!AAE6/&6'[G<I^>N'&UO8T6UN
M]$?><%9*\ZSBG"2_=T_?EZ)Z+_MYV7I=]#YXHHHKXT_LP***ZGX7^ ;SXH_$
M#0_"U@WE3ZE<"-IL*?)B +2R8++NV1J[;<@G;@<D548N345NS&M6IX>E*M5=
MHQ3;?9+5O[C[=_8#^%MMX?\ AU<^-IQ%-J6OR/# X 9H+6*1D*Y*@J6E5RP#
M%2$B/!!KZHJCH>BV?AO1=/TG3H?L^GV%O':VT.YFV1(H5%RQ).  ,DDU>K[>
MC25&FH+H?PSG>:3SG,:V.G]MZ)]([17R5D%%%%;GAA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7C5]^Q_P#"75+VXO+SPO+=W=Q(TTUQ/J]Z\DKL269F,V22222>23116<Z<
M*GQI/U._"9AC, V\)6E3OORR<;^MFB#_ (8Q^#G_ $)__E3O/_CU'_#&/P<_
MZ$__ ,J=Y_\ 'J**S^KT?Y%]R/2_UBSK_H-J_P#@R?\ F'_#&/P<_P"A/_\
M*G>?_'JZGX=_L_> ?A3K4^K>%=!_LO4)K=K62;[9<39B+*Q7$DC#JBG.,\44
M54:%*+O&"3]#&MGF:XBFZ5;%5)1>Z<Y-/U3=CT.BBBMCQ HHHH **** "BBB
0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140387658270240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000914475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">NEUROCRINE BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140387658086048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Aug. 01, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common stock, $0.001 par value per share, 2020 Equity Incentive Plan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,635,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">146.185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 531,382,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 78,432.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of Neurocrine Biosciences, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that become issuable under the Registrant&#8217;s 2020 Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant&#8217;s common stock, as applicable.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Estimated in accordance with Rule 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of 146.185 per share of common stock, which represents the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on July 26, 2024.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Represents 3,635,000 additional shares of Registrant&#8217;s common stock that were added to the shares authorized for issuance under the 2020 Plan on May 22, 2024 pursuant to approval of the stockholders at the 2024 Annual Meeting of Stockholders.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140387658242512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 01, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 531,382,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">78,432.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 78,432.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M V2X)>*1=I^@KR=0?"DE7']19W*]T$)IRP6M>K!T4)6U&?%+?PYC@'<&X/4
M3_LV0MKE+18XB1CM$%/9DDU-=*D:+<V5M;J4G6!RMY0XD=P!<+0S-Q+90C*J
M=3OMT1N#]LZ@UVT^0X[['GF.-T=/NUOT]O6[?VEL:6APY0VN/,WK7^$*_7R0
MN^A>0,5_35DT5/-I*O53KWB#4X@M^==R8$>PDC>OW-#Y>,&H/QCU+[$GWZC
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  4.0%9BY,"S>\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  4.0%9
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( !0Y 5DP'JC_3P(  #D&   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  4.0%9
MLB1Q#"@%  !V#0  &               @(&3"@  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ %#D!67P&N% I @  704  !@
M     ("!\0\  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M !0Y 5F8Z\VC) ,  /@1   -              "  5 2  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ %#D!69>*NQS     $P(   L              ( !
MGQ4  %]R96QS+RYR96QS4$L! A0#%     @ %#D!65)Q;[5= 0  2 ,   \
M             ( !B!8  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !0Y
M 5F[;.KLN@   !H#   :              "  1(8  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( !0Y 5FF_$I;(P$  -\$   3
M          "  009  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     +  L
*R@(  %@:      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="wk-20240731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wk-20240731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wk-20240731.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="wk-20240731.htm">wk-20240731.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "wk-20240731.htm": {
   "dts": {
    "inline": {
     "local": [
      "wk-20240731.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2024": 2,
    "http://xbrl.sec.gov/ffd/2024q2": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 17,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-2",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wk-20240731.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-2",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wk-20240731.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wk-20240731.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wk-20240731.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000914475-24-000183-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000914475-24-000183-xbrl.zip
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M!&@J1U$"S/D*%,IG(H+F/G/F:U",'RE(T<ZDB.B9A58PFR2Z!<9RW:F^1U$
M5* 365"JD-,P3*'91\84U*!Y;Z%I>8]3YRKM,=3% WOKYS3A--BFE=6/T38G
MQ5GBN?YW*Y86[R99/_&T[;:2/'<UYZ_0/EAM*M=?V7Z?P]+?[-XN==67^W]0
M2P$"% ,4    "  4.0%9,:>8<,8+  " 3P  #P              @ $
E=VLM,C R-# W,S$N:'1M4$L%!@     !  $ /0   /,+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>wk-20240731_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-01</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-01</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-1">0000914475</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-1" id="f-2">NEUROCRINE BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="c-1" id="f-3">S-8</ffd:FormTp>
    <ffd:SubmissnTp contextRef="c-1" id="f-4">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c-1" id="f-5">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:PrevslyPdFlg contextRef="c-2" id="f-6">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c-2" id="f-7">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c-2" id="f-8">Common stock, $0.001 par value per share, 2020 Equity Incentive Plan</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c-2" id="f-9">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd contextRef="c-2" decimals="0" id="f-10" unitRef="shares">3635000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty contextRef="c-2" decimals="3" id="f-11" unitRef="usd">146.185</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric contextRef="c-2" decimals="0" id="f-12" unitRef="usd">531382475</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c-2" decimals="7" id="f-13" unitRef="number">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c-2" decimals="2" id="f-14" unitRef="usd">78432.05</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c-1" decimals="0" id="f-15" unitRef="usd">531382475</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c-1" decimals="2" id="f-16" unitRef="usd">78432.05</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt contextRef="c-1" decimals="0" id="f-17" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c-1" decimals="2" id="f-18" unitRef="usd">78432.05</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c-2" id="f-19">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of Neurocrine Biosciences, Inc. (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registrant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) that become issuable under the Registrant&#x2019;s 2020 Equity Incentive Plan (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant&#x2019;s common stock, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) Estimated in accordance with Rule 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of 146.185 per share of common stock, which represents the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on July 26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) Represents 3,635,000 additional shares of Registrant&#x2019;s common stock that were added to the shares authorized for issuance under the 2020 Plan on May 22, 2024 pursuant to approval of the stockholders at the 2024 Annual Meeting of Stockholders.&lt;/span&gt;&lt;/div&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
